These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11865625)

  • 1. [Globalization of anti-cancer therapies].
    Akaza H; Aiba K; Isonishi S; Ikeda T; Ohashi Y; Kawai K; Saijo N; Saeki T; Sone S; Tsukagoshi S; Tsuruo T; Boku N; Kato M; Mikami O; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):205-14. PubMed ID: 11865625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
    Couteau C; Armand JP
    Bull Cancer; 1998 Dec; Spec No():47-50. PubMed ID: 9932085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New combination therapies for gastrointestinal cancer].
    Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takeda N
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):348-55. PubMed ID: 10740627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006.
    Green MR; Dowlati A; Yellamraju L; Daniels L; Willey J; Andrews M; Leff R
    J Thorac Oncol; 2007 Oct; 2(10):953-6. PubMed ID: 17909359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin versus cisplatin in ovarian cancer.
    Alberts DS
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [State of the treatment for gastrointestinal cancer].
    Baba H; Kohnoe S; Endo K; Ikeda Y; Toh Y; Nakashima H; Okamura T
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1233-46. PubMed ID: 10945022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
    Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR
    J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second-line chemotherapy for recurrent ovarian cancer].
    Sugiyama T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):28-32. PubMed ID: 15675578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
    Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
    Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese ovarian trials: focus on irinotecan.
    Sugiyama T; Yakushiji M; Ochiai K; Noda K
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):29-33. PubMed ID: 12800603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of platinum-resistant ovarian cancer].
    Onishi Y; Nakamura T; Hatae M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():554-9. PubMed ID: 15535307
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolving role of irinotecan in small-cell lung cancer.
    Spigel DR; Greco FA
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):482-5. PubMed ID: 16258436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of papillary adenocarcinoma of the ovary that responded favorably to irinotecan hydrochloride and cisplatin after the administration of paclitaxel and carboplatin].
    Shimoya K; Kunishige I; Okuno Y; Hayashi S; Komura H; Arimoto Y; Otsuki Y
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):845-8. PubMed ID: 11432356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel and carboplatin for advanced breast cancer.
    Perez EA; Hartmann LC
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):41-5. PubMed ID: 8893899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung cancer with bone metastasis].
    Katakami N
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1049-53. PubMed ID: 16912519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy in advanced gastric cancer--to ensure timely and appropriate switch to subsequent treatment options].
    Yamaguchi K; Shimamura T; Ishikubo T; Fujino K; Tada M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):29-34. PubMed ID: 17220666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.